NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.

The global NGS-Based Monitoring and Diagnostic Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for NGS-Based Monitoring and Diagnostic Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS-Based Monitoring and Diagnostic Test.

Report Scope

The NGS-Based Monitoring and Diagnostic Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NGS-Based Monitoring and Diagnostic Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NGS-Based Monitoring and Diagnostic Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of NGS-Based Monitoring and Diagnostic Test Market Report

Report Metric	Details
Report Name	NGS-Based Monitoring and Diagnostic Test Market
CAGR	5%
Segment by Type	Commercial Assays/Tests Laboratory Developed Tests Direct to Consumer Test Pre-Commercial Tests
Segment by Application	Out-Patient Clinics/General Practitioners Diagnostic Centers Hospitals Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx, Illumina, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Inc., Thermo Fisher Scientific Inc., HTG Molecular Diagnostics, Inc., Vela Diagnostics Pte. Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGS-Based Monitoring and Diagnostic Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the NGS-Based Monitoring and Diagnostic Test Market report?

Ans: The main players in the NGS-Based Monitoring and Diagnostic Test Market are Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx, Illumina, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Inc., Thermo Fisher Scientific Inc., HTG Molecular Diagnostics, Inc., Vela Diagnostics Pte. Ltd.

What are the Application segmentation covered in the NGS-Based Monitoring and Diagnostic Test Market report?

Ans: The Applications covered in the NGS-Based Monitoring and Diagnostic Test Market report are Out-Patient Clinics/General Practitioners, Diagnostic Centers, Hospitals, Others

What are the Type segmentation covered in the NGS-Based Monitoring and Diagnostic Test Market report?

Ans: The Types covered in the NGS-Based Monitoring and Diagnostic Test Market report are Commercial Assays/Tests, Laboratory Developed Tests, Direct to Consumer Test, Pre-Commercial Tests

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Commercial Assays/Tests

1.2.3 Laboratory Developed Tests

1.2.4 Direct to Consumer Test

1.2.5 Pre-Commercial Tests

1.3 Market by Application

1.3.1 Global NGS-Based Monitoring and Diagnostic Test Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Out-Patient Clinics/General Practitioners

1.3.3 Diagnostic Centers

1.3.4 Hospitals

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global NGS-Based Monitoring and Diagnostic Test Market Perspective (2019-2030)

2.2 NGS-Based Monitoring and Diagnostic Test Growth Trends by Region

2.2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 NGS-Based Monitoring and Diagnostic Test Historic Market Size by Region (2019-2024)

2.2.3 NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Region (2025-2030)

2.3 NGS-Based Monitoring and Diagnostic Test Market Dynamics

2.3.1 NGS-Based Monitoring and Diagnostic Test Industry Trends

2.3.2 NGS-Based Monitoring and Diagnostic Test Market Drivers

2.3.3 NGS-Based Monitoring and Diagnostic Test Market Challenges

2.3.4 NGS-Based Monitoring and Diagnostic Test Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NGS-Based Monitoring and Diagnostic Test Players by Revenue

3.1.1 Global Top NGS-Based Monitoring and Diagnostic Test Players by Revenue (2019-2024)

3.1.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Players (2019-2024)

3.2 Global NGS-Based Monitoring and Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by NGS-Based Monitoring and Diagnostic Test Revenue

3.4 Global NGS-Based Monitoring and Diagnostic Test Market Concentration Ratio

3.4.1 Global NGS-Based Monitoring and Diagnostic Test Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NGS-Based Monitoring and Diagnostic Test Revenue in 2023

3.5 NGS-Based Monitoring and Diagnostic Test Key Players Head office and Area Served

3.6 Key Players NGS-Based Monitoring and Diagnostic Test Product Solution and Service

3.7 Date of Enter into NGS-Based Monitoring and Diagnostic Test Market

3.8 Mergers & Acquisitions, Expansion Plans

4 NGS-Based Monitoring and Diagnostic Test Breakdown Data by Type

4.1 Global NGS-Based Monitoring and Diagnostic Test Historic Market Size by Type (2019-2024)

4.2 Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Type (2025-2030)

5 NGS-Based Monitoring and Diagnostic Test Breakdown Data by Application

5.1 Global NGS-Based Monitoring and Diagnostic Test Historic Market Size by Application (2019-2024)

5.2 Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America NGS-Based Monitoring and Diagnostic Test Market Size (2019-2030)

6.2 North America NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2019-2024)

6.4 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NGS-Based Monitoring and Diagnostic Test Market Size (2019-2030)

7.2 Europe NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2019-2024)

7.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size (2019-2030)

8.2 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region (2019-2024)

8.4 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NGS-Based Monitoring and Diagnostic Test Market Size (2019-2030)

9.2 Latin America NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2019-2024)

9.4 Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size (2019-2030)

10.2 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country (2019-2024)

10.4 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agilent Technologies, Inc.

11.1.1 Agilent Technologies, Inc. Company Detail

11.1.2 Agilent Technologies, Inc. Business Overview

11.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Introduction

11.1.4 Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.1.5 Agilent Technologies, Inc. Recent Development

11.2 Ancestry.com LLC

11.2.1 Ancestry.com LLC Company Detail

11.2.2 Ancestry.com LLC Business Overview

11.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Introduction

11.2.4 Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.2.5 Ancestry.com LLC Recent Development

11.3 ArcherDX, Inc.

11.3.1 ArcherDX, Inc. Company Detail

11.3.2 ArcherDX, Inc. Business Overview

11.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Introduction

11.3.4 ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.3.5 ArcherDX, Inc. Recent Development

11.4 Beijing Genomics Institute (BGI)

11.4.1 Beijing Genomics Institute (BGI) Company Detail

11.4.2 Beijing Genomics Institute (BGI) Business Overview

11.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Introduction

11.4.4 Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.4.5 Beijing Genomics Institute (BGI) Recent Development

11.5 Cancer Genetics, Inc.

11.5.1 Cancer Genetics, Inc. Company Detail

11.5.2 Cancer Genetics, Inc. Business Overview

11.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction

11.5.4 Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.5.5 Cancer Genetics, Inc. Recent Development

11.6 CENTOGENE AG

11.6.1 CENTOGENE AG Company Detail

11.6.2 CENTOGENE AG Business Overview

11.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Introduction

11.6.4 CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.6.5 CENTOGENE AG Recent Development

11.7 F. Hoffmann-La Roche Ltd

11.7.1 F. Hoffmann-La Roche Ltd Company Detail

11.7.2 F. Hoffmann-La Roche Ltd Business Overview

11.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Introduction

11.7.4 F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.7.5 F. Hoffmann-La Roche Ltd Recent Development

11.8 GenePath Dx

11.8.1 GenePath Dx Company Detail

11.8.2 GenePath Dx Business Overview

11.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Introduction

11.8.4 GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.8.5 GenePath Dx Recent Development

11.9 Illumina, Inc.

11.9.1 Illumina, Inc. Company Detail

11.9.2 Illumina, Inc. Business Overview

11.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Introduction

11.9.4 Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.9.5 Illumina, Inc. Recent Development

11.10 Laboratory Corporation of America Holdings

11.10.1 Laboratory Corporation of America Holdings Company Detail

11.10.2 Laboratory Corporation of America Holdings Business Overview

11.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Introduction

11.10.4 Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.10.5 Laboratory Corporation of America Holdings Recent Development

11.11 Myriad Genetics, Inc.

11.11.1 Myriad Genetics, Inc. Company Detail

11.11.2 Myriad Genetics, Inc. Business Overview

11.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction

11.11.4 Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.11.5 Myriad Genetics, Inc. Recent Development

11.12 QIAGEN N.V.

11.12.1 QIAGEN N.V. Company Detail

11.12.2 QIAGEN N.V. Business Overview

11.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Introduction

11.12.4 QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.12.5 QIAGEN N.V. Recent Development

11.13 Quest Diagnostics Incorporated

11.13.1 Quest Diagnostics Incorporated Company Detail

11.13.2 Quest Diagnostics Incorporated Business Overview

11.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Introduction

11.13.4 Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.13.5 Quest Diagnostics Incorporated Recent Development

11.14 Siemens Healthineers, Inc.

11.14.1 Siemens Healthineers, Inc. Company Detail

11.14.2 Siemens Healthineers, Inc. Business Overview

11.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Introduction

11.14.4 Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.14.5 Siemens Healthineers, Inc. Recent Development

11.15 Thermo Fisher Scientific Inc.

11.15.1 Thermo Fisher Scientific Inc. Company Detail

11.15.2 Thermo Fisher Scientific Inc. Business Overview

11.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Introduction

11.15.4 Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.15.5 Thermo Fisher Scientific Inc. Recent Development

11.16 HTG Molecular Diagnostics, Inc.

11.16.1 HTG Molecular Diagnostics, Inc. Company Detail

11.16.2 HTG Molecular Diagnostics, Inc. Business Overview

11.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction

11.16.4 HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.16.5 HTG Molecular Diagnostics, Inc. Recent Development

11.17 Vela Diagnostics Pte. Ltd.

11.17.1 Vela Diagnostics Pte. Ltd. Company Detail

11.17.2 Vela Diagnostics Pte. Ltd. Business Overview

11.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Introduction

11.17.4 Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

11.17.5 Vela Diagnostics Pte. Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Agilent Technologies Inc

Ancestry.com LLC

Archerdx

Beijing Genomics Institute (BGI)

Cancer Genetics Inc.

CENTOGENE

F Hoffmann La Roche Ltd

GenePath Dx

Illumina Inc

Laboratory Corporation of America Holdings

Myriad Genetics Inc

QIAGEN N V

Quest Diagnostics Incorporated

Siemens Healthineers Inc

Thermo Fisher Scientific Inc

HTG Molecular Diagnostics, Inc.

Vela Diagnostics Pte. Ltd.

List of Tables

Table 1. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Commercial Assays/Tests

Table 3. Key Players of Laboratory Developed Tests

Table 4. Key Players of Direct to Consumer Test

Table 5. Key Players of Pre-Commercial Tests

Table 6. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global NGS-Based Monitoring and Diagnostic Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global NGS-Based Monitoring and Diagnostic Test Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global NGS-Based Monitoring and Diagnostic Test Market Share by Region (2019-2024)

Table 10. Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global NGS-Based Monitoring and Diagnostic Test Market Share by Region (2025-2030)

Table 12. NGS-Based Monitoring and Diagnostic Test Market Trends

Table 13. NGS-Based Monitoring and Diagnostic Test Market Drivers

Table 14. NGS-Based Monitoring and Diagnostic Test Market Challenges

Table 15. NGS-Based Monitoring and Diagnostic Test Market Restraints

Table 16. Global NGS-Based Monitoring and Diagnostic Test Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global NGS-Based Monitoring and Diagnostic Test Market Share by Players (2019-2024)

Table 18. Global Top NGS-Based Monitoring and Diagnostic Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2023)

Table 19. Ranking of Global Top NGS-Based Monitoring and Diagnostic Test Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by NGS-Based Monitoring and Diagnostic Test Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players NGS-Based Monitoring and Diagnostic Test Product Solution and Service

Table 23. Date of Enter into NGS-Based Monitoring and Diagnostic Test Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type (2019-2024)

Table 27. Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type (2025-2030)

Table 29. Global NGS-Based Monitoring and Diagnostic Test Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application (2019-2024)

Table 31. Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application (2025-2030)

Table 33. North America NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country (2025-2030) & (US$ Million)

Table 48. Agilent Technologies, Inc. Company Detail

Table 49. Agilent Technologies, Inc. Business Overview

Table 50. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product

Table 51. Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 52. Agilent Technologies, Inc. Recent Development

Table 53. Ancestry.com LLC Company Detail

Table 54. Ancestry.com LLC Business Overview

Table 55. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product

Table 56. Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 57. Ancestry.com LLC Recent Development

Table 58. ArcherDX, Inc. Company Detail

Table 59. ArcherDX, Inc. Business Overview

Table 60. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product

Table 61. ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 62. ArcherDX, Inc. Recent Development

Table 63. Beijing Genomics Institute (BGI) Company Detail

Table 64. Beijing Genomics Institute (BGI) Business Overview

Table 65. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product

Table 66. Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 67. Beijing Genomics Institute (BGI) Recent Development

Table 68. Cancer Genetics, Inc. Company Detail

Table 69. Cancer Genetics, Inc. Business Overview

Table 70. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product

Table 71. Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 72. Cancer Genetics, Inc. Recent Development

Table 73. CENTOGENE AG Company Detail

Table 74. CENTOGENE AG Business Overview

Table 75. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product

Table 76. CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 77. CENTOGENE AG Recent Development

Table 78. F. Hoffmann-La Roche Ltd Company Detail

Table 79. F. Hoffmann-La Roche Ltd Business Overview

Table 80. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product

Table 81. F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 82. F. Hoffmann-La Roche Ltd Recent Development

Table 83. GenePath Dx Company Detail

Table 84. GenePath Dx Business Overview

Table 85. GenePath Dx NGS-Based Monitoring and Diagnostic Test Product

Table 86. GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 87. GenePath Dx Recent Development

Table 88. Illumina, Inc. Company Detail

Table 89. Illumina, Inc. Business Overview

Table 90. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product

Table 91. Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 92. Illumina, Inc. Recent Development

Table 93. Laboratory Corporation of America Holdings Company Detail

Table 94. Laboratory Corporation of America Holdings Business Overview

Table 95. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product

Table 96. Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 97. Laboratory Corporation of America Holdings Recent Development

Table 98. Myriad Genetics, Inc. Company Detail

Table 99. Myriad Genetics, Inc. Business Overview

Table 100. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product

Table 101. Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 102. Myriad Genetics, Inc. Recent Development

Table 103. QIAGEN N.V. Company Detail

Table 104. QIAGEN N.V. Business Overview

Table 105. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product

Table 106. QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 107. QIAGEN N.V. Recent Development

Table 108. Quest Diagnostics Incorporated Company Detail

Table 109. Quest Diagnostics Incorporated Business Overview

Table 110. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product

Table 111. Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 112. Quest Diagnostics Incorporated Recent Development

Table 113. Siemens Healthineers, Inc. Company Detail

Table 114. Siemens Healthineers, Inc. Business Overview

Table 115. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product

Table 116. Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 117. Siemens Healthineers, Inc. Recent Development

Table 118. Thermo Fisher Scientific Inc. Company Detail

Table 119. Thermo Fisher Scientific Inc. Business Overview

Table 120. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product

Table 121. Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 122. Thermo Fisher Scientific Inc. Recent Development

Table 123. HTG Molecular Diagnostics, Inc. Company Detail

Table 124. HTG Molecular Diagnostics, Inc. Business Overview

Table 125. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product

Table 126. HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 127. HTG Molecular Diagnostics, Inc. Recent Development

Table 128. Vela Diagnostics Pte. Ltd. Company Detail

Table 129. Vela Diagnostics Pte. Ltd. Business Overview

Table 130. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product

Table 131. Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2019-2024) & (US$ Million)

Table 132. Vela Diagnostics Pte. Ltd. Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NGS-Based Monitoring and Diagnostic Test Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global NGS-Based Monitoring and Diagnostic Test Market Share by Type: 2023 VS 2030

Figure 3. Commercial Assays/Tests Features

Figure 4. Laboratory Developed Tests Features

Figure 5. Direct to Consumer Test Features

Figure 6. Pre-Commercial Tests Features

Figure 7. Global NGS-Based Monitoring and Diagnostic Test Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application: 2023 VS 2030

Figure 9. Out-Patient Clinics/General Practitioners Case Studies

Figure 10. Diagnostic Centers Case Studies

Figure 11. Hospitals Case Studies

Figure 12. Others Case Studies

Figure 13. NGS-Based Monitoring and Diagnostic Test Report Years Considered

Figure 14. Global NGS-Based Monitoring and Diagnostic Test Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global NGS-Based Monitoring and Diagnostic Test Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global NGS-Based Monitoring and Diagnostic Test Market Share by Region: 2023 VS 2030

Figure 17. Global NGS-Based Monitoring and Diagnostic Test Market Share by Players in 2023

Figure 18. Global Top NGS-Based Monitoring and Diagnostic Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by NGS-Based Monitoring and Diagnostic Test Revenue in 2023

Figure 20. North America NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America NGS-Based Monitoring and Diagnostic Test Market Share by Country (2019-2030)

Figure 22. United States NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe NGS-Based Monitoring and Diagnostic Test Market Share by Country (2019-2030)

Figure 26. Germany NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Share by Region (2019-2030)

Figure 34. China NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America NGS-Based Monitoring and Diagnostic Test Market Share by Country (2019-2030)

Figure 42. Mexico NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Share by Country (2019-2030)

Figure 46. Turkey NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Agilent Technologies, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 49. Ancestry.com LLC Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 50. ArcherDX, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 51. Beijing Genomics Institute (BGI) Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 52. Cancer Genetics, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 53. CENTOGENE AG Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 54. F. Hoffmann-La Roche Ltd Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 55. GenePath Dx Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 56. Illumina, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 57. Laboratory Corporation of America Holdings Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 58. Myriad Genetics, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 59. QIAGEN N.V. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 60. Quest Diagnostics Incorporated Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 61. Siemens Healthineers, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 62. Thermo Fisher Scientific Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 63. HTG Molecular Diagnostics, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 64. Vela Diagnostics Pte. Ltd. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions